U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972732) titled 'A Phase IV Clinical Study to Compared the Efficacy and Safety of Switching Metformin+SGLT2-i+DPP4-i to Metformin+SGLT2-i+TZD in Patients With Type 2 Diabetes' on May 07.
Brief Summary: This is a randomized, open-label, active-controlled, parallel, multicenter, phase IV clinical study evaluating the efficacy and safety of switching Metformin+SGLT2-i+DPP4-i to Metformin+SGLT2-i+TZD in patients with type 2 diabetes.
Study Start Date: May 30
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: Metformin
The dosage and dose frequency are maintained as they were before the screening.
DRUG: Dapagliflozin/Pioglit...